Compass Wealth Management LLC has acquired a new stake of 3,634 shares, valued at $2.04 million, in Regeneron Pharmaceuticals (NASDAQ:REGN) during the third quarter. Other institutional investors have also significantly increased their holdings in the biopharmaceutical company. Analysts currently have an average rating of “Moderate Buy” for REGN with a consensus target price of $793.81.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Compass Wealth Management LLC Invests $2.04 Million in Regeneron Pharmaceuticals, Inc. $REGN
Compass Wealth Management LLC has acquired a new stake of 3,634 shares, valued at $2.04 million, in Regeneron Pharmaceuticals (NASDAQ:REGN) during the third quarter. Other institutional investors have also significantly increased their holdings in the biopharmaceutical company. Analysts currently have an average rating of “Moderate Buy” for REGN with a consensus target price of $793.81.